Ciena vs Koninklijke Philips NV — how do they compare? Ciena trades at $265.25 (market cap $37.55B), while Koninklijke Philips NV trades at $29.89 (market cap $29.20B). The key difference: Ciena is the larger of the two by market cap, and Koninklijke Philips NV pays a 3.39% dividend while Ciena pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ciena for 16 Days and Koninklijke Philips NV for 87 Days on average.
| CIEN | PHG | |
|---|---|---|
Market Cap | $37.55B | $29.20B |
Volume | 2,437,327 | 930,713 |
Sector | Technology | Health |
52-Week High | $627.00 | $32.91 |
52-Week Low | $176.45 | $23.81 |
Typical Hold Time | 16 Days | 87 Days |
Enterprise Value | $38.21B | $35.13B |
Dividend Yield | — | 3.39% |
Signals from Pluang's Aura AI — not financial advice
Ciena Corporation (CIEN) trades at $266.22, up 3.36% with strong earnings momentum after beating Q2 2026 EPS estimates. The stock shows bearish technical signals but benefits from robust analyst support with a $507.42 consensus price target. Recent news highlights 30%+ revenue growth expectations for FY2027 driven by AI infrastructure demand and optical networking expansion.
Ciena presents a compelling growth story with strong fundamentals but faces technical headwinds. The company's AI-driven optical networking positioning offers substantial upside potential, though investors should monitor competitive pressures and execution risks amid high valuation multiples.
PHG trades at $29.81, down 1.09% today, with a bullish technical signal from moving averages. The company reported strong Q1-Q3 2026 earnings beats and positive net income of $895M in 2025 after recent losses. Recent news highlights product launches in healthcare technology and a $33.7M ARPA-H award for AI-enabled stroke care.
Outlook: Improved profitability and innovation in health tech support growth, but mixed analyst ratings and cybersecurity risks warrant caution. Investment opportunity lies in execution of recent contracts and margin expansion, balanced against competitive and regulatory pressures in the healthcare sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Ciena provides networking systems, components, automation software, and services for high-speed connectivity. Its products are used to transmit and manage data across telecom, cloud, and data center networks.
Read more on CIEN →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →